The cytogenetics of myelodysplastic syndromes
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (3) , 479-495
- https://doi.org/10.1053/beha.2001.0151
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromesBritish Journal of Haematology, 2000
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- X-inactivation analysis in the 1990s: promise and potential problemsLeukemia, 1998
- 5q-, twenty-five years later: a SynopsisCancer Genetics and Cytogenetics, 1997
- The 17p-Syndrome: A Distinct Myelodysplastic Syndrome Entity?Leukemia & Lymphoma, 1997
- Diagnostic and Prognostic Significance of Cytogenetics in Adult Primary Myelodysplastic SyndromesLeukemia & Lymphoma, 1996
- The concept of preleukemia: Clinical and laboratory studiesCritical Reviews in Oncology/Hematology, 1986
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Three patients with structurally abnormal X chromosomes, each with Xq13 breakpoints and a history of idiopathic acquired sideroblastic anemiaBlood, 1982
- A common progenitor for human myeloid and lymphoid cellsNature, 1978